Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Breier

Showing results (111-120 of 269) with videos related to

Pageof 27
Sort By:
Lancet (London, England)|October 7, 1997
Apolipoprotein E epsilon 4 and clinical phenotype in schizophreniaD Pickar, A K Malhotra, W Rooney, et al.
General Physiology and Biophysics|January 11, 2005
Functional fluo-3/AM assay on P-glycoprotein transport activity in L1210/VCR cells by confocal microscopyJ Orlický, Z Sulová, I Dovinová, et al.
Bratislavske Lekarske Listy|March 1, 1990
[The role of Na(+) pump inhibition induced by Ca2(+) ions in the development of pathologic changes during calcium overload in myocardial cells]A Breier, V Durisová, R Monosíková, et al.
Neuropsychiatry, Neuropsychology, and Behavioral Neurology|January 25, 2000
The relation between dopamine D2 receptor density and personality: preliminary evidence from the NEO personality inventory-revisedL P Kestler, A K Malhotra, C Finch, et al.
General Physiology and Biophysics|June 1, 1985
Exaprolol as a modulator of heart sarcolemmal (Na+ + K+)-ATPase. Evidence for interaction with an essential sulfhydryl group in the catalytic centre of the enzymeA Dzurba, A Ziegelhöffer, L Schmidtová, et al.
Archives of General Psychiatry|October 24, 1997
D2 dopamine receptor occupancy: a crossover comparison of risperidone with clozapine therapy in schizophrenic patientsT P Su, A K Malhotra, K Hadd, et al.
General Physiology and Biophysics|August 1, 1985
Quantitative relationship between the protein secondary structure in cardiac sarcolemma and the activity of the membrane-bound Ca2+-ATPaseN Vrbjar, A Ziegelhöffer, A Breier, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 18, 2001
SB203580, a specific inhibitor of p38-MAPK pathway, is a new reversal agent of P-glycoprotein-mediated multidrug resistanceM Barancík, V Bohácová, J Kvackajová, et al.
General Physiology and Biophysics|October 1, 1994
Inhibition of (Na/K)-ATPase by NFE induces an increase in mechanical activity of perfused guinea-pig heartA Vrbanová, T Stankovicová, P Docolomanský, et al.
Drugs Under Experimental and Clinical Research|January 1, 1994
Reversal effects of several Ca(2+)-entry blockers, neuroleptics and local anaesthetics on P-glycoprotein-mediated vincristine resistance of L1210/VCR mouse leukaemic cell lineM Barancík, L Poleková, T Mrázová, et al.
Pageof 27

Showing results (111-120 of 269) with videos related to

Sort By:
Pageof 27
Lancet (London, England)|October 7, 1997
Apolipoprotein E epsilon 4 and clinical phenotype in schizophreniaD Pickar, A K Malhotra, W Rooney, et al.
General Physiology and Biophysics|January 11, 2005
Functional fluo-3/AM assay on P-glycoprotein transport activity in L1210/VCR cells by confocal microscopyJ Orlický, Z Sulová, I Dovinová, et al.
Bratislavske Lekarske Listy|March 1, 1990
[The role of Na(+) pump inhibition induced by Ca2(+) ions in the development of pathologic changes during calcium overload in myocardial cells]A Breier, V Durisová, R Monosíková, et al.
Neuropsychiatry, Neuropsychology, and Behavioral Neurology|January 25, 2000
The relation between dopamine D2 receptor density and personality: preliminary evidence from the NEO personality inventory-revisedL P Kestler, A K Malhotra, C Finch, et al.
General Physiology and Biophysics|June 1, 1985
Exaprolol as a modulator of heart sarcolemmal (Na+ + K+)-ATPase. Evidence for interaction with an essential sulfhydryl group in the catalytic centre of the enzymeA Dzurba, A Ziegelhöffer, L Schmidtová, et al.
Archives of General Psychiatry|October 24, 1997
D2 dopamine receptor occupancy: a crossover comparison of risperidone with clozapine therapy in schizophrenic patientsT P Su, A K Malhotra, K Hadd, et al.
General Physiology and Biophysics|August 1, 1985
Quantitative relationship between the protein secondary structure in cardiac sarcolemma and the activity of the membrane-bound Ca2+-ATPaseN Vrbjar, A Ziegelhöffer, A Breier, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 18, 2001
SB203580, a specific inhibitor of p38-MAPK pathway, is a new reversal agent of P-glycoprotein-mediated multidrug resistanceM Barancík, V Bohácová, J Kvackajová, et al.
General Physiology and Biophysics|October 1, 1994
Inhibition of (Na/K)-ATPase by NFE induces an increase in mechanical activity of perfused guinea-pig heartA Vrbanová, T Stankovicová, P Docolomanský, et al.
Drugs Under Experimental and Clinical Research|January 1, 1994
Reversal effects of several Ca(2+)-entry blockers, neuroleptics and local anaesthetics on P-glycoprotein-mediated vincristine resistance of L1210/VCR mouse leukaemic cell lineM Barancík, L Poleková, T Mrázová, et al.
Pageof 27